C.H. Robinson Worldwide Operating Cash Flow decreased by 77.5% to $68.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.6%, from $106.53M to $68.60M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows a downward trend with a -17.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.29M | $75.86M | -$13.93M | $265.26M | $625.46M | $773.38M | $254.54M | $224.83M | $205.24M | $47.33M | -$33.32M | $166.42M | $108.06M | $267.93M | $106.53M | $227.13M | $275.45M | $305.41M | $68.60M |
| QoQ Change | — | -49.2% | -118.4% | >999% | +135.8% | +23.7% | -67.1% | -11.7% | -8.7% | -76.9% | -170.4% | +599.4% | -35.1% | +148.0% | -60.2% | +113.2% | +21.3% | +10.9% | -77.5% |
| YoY Change | — | — | — | +77.7% | — | +919.6% | >999% | -15.2% | -67.2% | -93.9% | -113.1% | -26.0% | -47.4% | +466.1% | +419.7% | +36.5% | +154.9% | +14.0% | -35.6% |